María Fernanda
López Fernández
KU Leuven
Lovaina, BélgicaPublicacións en colaboración con investigadores/as de KU Leuven (2)
2023
-
Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1
Journal of Thrombosis and Haemostasis
2015
-
Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity
Acta Haematologica, Vol. 134, Núm. 4, pp. 215-228